Encyclopedia of Biopharmaceutical Statistics 2nd Ed. - (Malestrom)

Creation Time	Sept. 11, 2025, 7:34 a.m.
Last Access Time	Sept. 13, 2025, 6:40 p.m.
File Size	62.0 MB
Keywords	Malestrom Statistics of - 2nd Biopharmaceutical Ed Encyclopedia
Total Requests	7
Total Files	197
Magnet Link	Please wait ...
	Download (Magnet Link) Play (Watch Online)

Ac-As/Analysis of Variance.pdf 1.6 MB
Ka-Mu/Microarray Gene Expression.pdf 1.1 MB
Ba-Ca to Ce-Cu/Biopharmaceutics.pdf 1.1 MB
No-Pr/Pharmacoeconomics.pdf 1017.6 KB
Qt-St to Su-Zs/Validation of Quantitative and Qualitative Assays.pdf 988.6 KB
No-Pr/Process Validation.pdf 987.4 KB
Qt-St to Su-Zs/Response Surface Methodology.pdf 976.8 KB
Da-Fa to Fo-In/Extra Variation Models.pdf 925.0 KB
Ka-Mu/Logistic Regression.pdf 876.7 KB
Qt-St to Su-Zs/Statistical Process Control.pdf 799.2 KB
Ba-Ca to Ce-Cu/Clinical Data Management.pdf 784.9 KB
Da-Fa to Fo-In/Factorial Designs.pdf 738.4 KB
Qt-St to Su-Zs/Vaccine Clinical Trials.pdf 710.0 KB
Ba-Ca to Ce-Cu/Comparing Variabilities in Clinical Research.pdf 680.6 KB
Da-Fa to Fo-In/ED50-ED90.pdf 676.5 KB
Qt-St to Su-Zs/Sample Size Determination.pdf 657.5 KB
Qt-St to Su-Zs/ROC Curve.pdf 654.3 KB
Da-Fa to Fo-In/Interactive Voice Randomization System (IVRS).pdf 649.6 KB
Qt-St to Su-Zs/Slope Approach for Assessment of Dose Proportionality-Linearity Under a Crossover Design.pdf 643.4 KB
No-Pr/Postmarketing Adverse Drug Event Signaling.pdf 618.9 KB
Da-Fa to Fo-In/In Vitro Micronucleus Test.pdf 606.7 KB
Da-Fa to Fo-In/Exploratory Factor Analysis.pdf 602.2 KB
Ka-Mu/Ministry of Health, Labour and Welfare and Pharmaceutical Administration in Japan.pdf 596.1 KB
Ka-Mu/Kaplan-Meier Estimator.pdf 589.8 KB
Qt-St to Su-Zs/Robust Analysis for Crossover Design.pdf 583.0 KB
Qt-St to Su-Zs/Toxicological Studies.pdf 578.0 KB
Ka-Mu/Meta-Analysis of Therapeutic Trials.pdf 577.7 KB
Ka-Mu/Lilly Reference Ranges.pdf 563.4 KB
Da-Fa to Fo-In/Interim Analysis.pdf 560.8 KB
No-Pr/Outlier Detection in Clinical Research.pdf 558.6 KB
Qt-St to Su-Zs/Spatio-Temporal Modeling.pdf 553.6 KB
Qt-St to Su-Zs/Survival Analysis.pdf 546.9 KB
No-Pr/P-Values.pdf 537.7 KB
No-Pr/Pharmacodynamics with Covariates.pdf 524.2 KB
Da-Fa to Fo-In/Integrated Summary Report.pdf 511.4 KB
Ba-Ca to Ce-Cu/Carcinogenicity Studies of Pharmaceuticals.pdf 506.0 KB
Da-Fa to Fo-In/Dose Proportionality.pdf 479.7 KB
Qt-St to Su-Zs/Reproducibility Probability in Clinical Research.pdf 474.6 KB
Ka-Mu/Medical Devices.pdf 468.1 KB
Da-Fa to Fo-In/Investigating Quality-of-Life in Clinical Trials.pdf 464.6 KB
Da-Fa to Fo-In/Data Mining and Biopharmaceutical Research.pdf 461.4 KB
Ka-Mu/Measuring Agreement.pdf 454.6 KB
No-Pr/P-Values, Evidence and Multiplicity Considerations for Controlled Clinical Trials.pdf 450.3 KB
Da-Fa to Fo-In/Instrument Development and Validation.pdf 435.6 KB
Ba-Ca to Ce-Cu/Biologics.pdf 428.0 KB
Ac-As/Acceptance Sampling.pdf 427.0 KB
Da-Fa to Fo-In/Data Monitoring Committees (DMC).pdf 425.5 KB
Ac-As/Assay Development.pdf 424.0 KB
Ac-As/Assay Validation.pdf 420.2 KB
Da-Fa to Fo-In/Group Sequential Methods.pdf 413.0 KB
Ac-As/Ames Test.pdf 406.0 KB
Qt-St to Su-Zs/Sample Size Calculation Based on Nonparametric Statistics.pdf 372.4 KB
No-Pr/Pharmacodynamics with No Covariates.pdf 371.3 KB
Da-Fa to Fo-In/Diagnostic Imaging.pdf 367.6 KB
Qt-St to Su-Zs/Subgroup Analysis.pdf 360.4 KB
Da-Fa to Fo-In/Genetic Linkage and Linkage Disequilibrium Analysis.pdf 353.3 KB
Ka-Mu/Maximum Tolerable Dose for Cancer Chemotherapy.pdf 350.5 KB
No-Pr/Pharmacodynamic Issues.pdf 348.7 KB
No-Pr/Proportional Hazards Regression Model.pdf 343.7 KB
Qt-St to Su-Zs/Reproductive-Developmental Studies.pdf 342.2 KB
Ba-Ca to Ce-Cu/Bayesian Statistics.pdf 337.8 KB
Ba-Ca to Ce-Cu/Calibration.pdf 336.9 KB
No-Pr/Phase I Cancer Clinical Trials.pdf 335.0 KB
Ka-Mu/Modified Large Sample Method.pdf 333.4 KB
Da-Fa to Fo-In/Individual Bioequivalence.pdf 333.1 KB
Ba-Ca to Ce-Cu/Cutoff Designs.pdf 330.0 KB
No-Pr/Postmarketing Surveillance.pdf 328.6 KB
Da-Fa to Fo-In/Dose Response Study Design.pdf 327.3 KB
Ba-Ca to Ce-Cu/Cancer Trials.pdf 324.2 KB
Ba-Ca to Ce-Cu/Crossover Design.pdf 323.4 KB
Da-Fa to Fo-In/Global Database and System.pdf 319.8 KB
Ka-Mu/Laboratory Analyses.pdf 313.7 KB
Da-Fa to Fo-In/False Discovery Rate (FDR).pdf 310.4 KB
Ka-Mu/Multinational Clinical Trial.pdf 309.0 KB
Da-Fa to Fo-In/Expiration Dating Period.pdf 304.7 KB
No-Pr/Population Bioequivalence.pdf 304.2 KB
Ac-As/Active Control Trials.pdf 303.7 KB
Da-Fa to Fo-In/Food and Drug Administration.pdf 302.9 KB
Da-Fa to Fo-In/Hypotheses and False Positive Rate in Active Control Non-Inferiority Trials.pdf 302.4 KB
Qt-St to Su-Zs/Sample Size Calculation for Survival Data.pdf 301.6 KB
Da-Fa to Fo-In/In Vitro Dissolution Profile Comparison.pdf 300.1 KB
Da-Fa to Fo-In/In Vitro Bioequivalence Testing.pdf 300.1 KB
Qt-St to Su-Zs/Validity of LOCF.pdf 298.8 KB
Da-Fa to Fo-In/Drug Development.pdf 295.0 KB
Qt-St to Su-Zs/Reliability.pdf 293.2 KB
No-Pr/Odds Ratio.pdf 293.2 KB
Ba-Ca to Ce-Cu/Confounding and Interaction.pdf 284.0 KB
Ac-As/Adverse Event Reporting.pdf 280.2 KB
Da-Fa to Fo-In/Good Clinical Practice.pdf 276.8 KB
Da-Fa to Fo-In/Good Programming Practice.pdf 275.3 KB
Ka-Mu/MedDRA and Its Impact on Pharmaceutical Development.pdf 272.1 KB
Ba-Ca to Ce-Cu/Blinding.pdf 271.5 KB
Qt-St to Su-Zs/Release Targets.pdf 267.6 KB
Ba-Ca to Ce-Cu/Bootstrap, The.pdf 265.0 KB
Ac-As/Analysis of Heritability.pdf 263.5 KB
Ba-Ca to Ce-Cu/Clustered Study Designs- Power Analysis.pdf 259.3 KB
Da-Fa to Fo-In/Imputation with Item Nonrespondents.pdf 257.7 KB
Ba-Ca to Ce-Cu/Bioavailability and Bioequivalence.pdf 255.0 KB
Qt-St to Su-Zs/Therapeutic Equivalence.pdf 252.5 KB
Ba-Ca to Ce-Cu/Carry-Forward Analysis.pdf 252.3 KB
Da-Fa to Fo-In/Equivalence Trials.pdf 251.3 KB
Da-Fa to Fo-In/Dropout.pdf 250.7 KB
Ba-Ca to Ce-Cu/Cost-Effectiveness Analysis.pdf 247.1 KB
Da-Fa to Fo-In/Dose Response Analysis in Clinical Trials.pdf 245.7 KB
No-Pr/Patient Compliance.pdf 245.7 KB
No-Pr/Population PK-PD Analysis.pdf 245.1 KB
Qt-St to Su-Zs/Selection of Control in Clinical Trials.pdf 243.4 KB
Qt-St to Su-Zs/Stability Matrix Designs.pdf 242.4 KB
Da-Fa to Fo-In/Good Statistics Practice.pdf 238.6 KB
Ka-Mu/Kullback-Leibler Divergence for Evaluating Equivalence.pdf 230.3 KB
Ba-Ca to Ce-Cu/Canadian Health Products and Food Branch (HPFB) and Therapeutic Products Directorate (TPD).pdf 227.7 KB
Qt-St to Su-Zs/Statistical Significance.pdf 222.4 KB
Qt-St to Su-Zs/Randomization.pdf 221.7 KB
Qt-St to Su-Zs/Rank Regression in Stability Analysis.pdf 218.9 KB
Ka-Mu/Mixed Effects Models.pdf 217.6 KB
Qt-St to Su-Zs/Stability Analysis for Frozen Drug Products.pdf 217.6 KB
No-Pr/Placebo Effect.pdf 216.1 KB
No-Pr/Parallel Design.pdf 215.7 KB
Qt-St to Su-Zs/Subject-Treatment Interaction.pdf 214.4 KB
Ba-Ca to Ce-Cu/Bridging Studies.pdf 213.6 KB
Qt-St to Su-Zs/Sample Size Re-estimation Based on Observed Treatment Difference.pdf 213.1 KB
No-Pr/Profile Analysis.pdf 212.5 KB
Ka-Mu/Minimization Procedure.pdf 210.4 KB
Ka-Mu/Minimum Effective Dose.pdf 210.4 KB
Qt-St to Su-Zs/Titration Design.pdf 210.3 KB
Ba-Ca to Ce-Cu/Contract Research Organization (CRO).pdf 204.9 KB
Qt-St to Su-Zs/Statistical Principles for Clinical Trials.pdf 203.0 KB
Ba-Ca to Ce-Cu/Case-Control Studies, Inference in.pdf 200.7 KB
Ba-Ca to Ce-Cu/Content Uniformity.pdf 198.7 KB
Qt-St to Su-Zs/SROC Curve.pdf 192.3 KB
Ba-Ca to Ce-Cu/Confidence Interval and Hypothesis Testing.pdf 187.5 KB
No-Pr/Prediction Trees.pdf 184.5 KB
Da-Fa to Fo-In/Ecologic Inference.pdf 180.0 KB
Da-Fa to Fo-In/Generalizability Probability in Clinical Research.pdf 178.7 KB
Da-Fa to Fo-In/Generalized Estimating Equation.pdf 178.7 KB
Da-Fa to Fo-In/Imputation in Clinical Research.pdf 177.5 KB
No-Pr/Percentile Charts on Correlated Measures.pdf 177.1 KB
No-Pr/Noninferiority Analysis in Active Controlled Clinical Trials.pdf 174.9 KB
Ba-Ca to Ce-Cu/Cluster Trials.pdf 173.1 KB
Ka-Mu/Multicenter Trials.pdf 172.0 KB
Da-Fa to Fo-In/Intention-to-Treat Analyses (ITT).pdf 171.8 KB
Qt-St to Su-Zs/QT Analysis.pdf 170.4 KB
Ac-As/Adjustment for Covariates.pdf 169.4 KB
No-Pr/Protocol Development.pdf 169.0 KB
Ba-Ca to Ce-Cu/Combination Drug Clinical Trial.pdf 169.0 KB
Ba-Ca to Ce-Cu/Clinical Endpoint.pdf 166.4 KB
Ba-Ca to Ce-Cu/Clinical Trial Process.pdf 165.0 KB
Qt-St to Su-Zs/Two-Stage Design- Phase II Cancer Clinical Trials.pdf 163.9 KB
Da-Fa to Fo-In/International Conference on Harmonization (ICH).pdf 161.7 KB
Ka-Mu/Latent Class Analysis.pdf 155.9 KB
Da-Fa to Fo-In/Failure-Time Model.pdf 155.4 KB
Ac-As/Adaptive Dose-Finding Based on Efficacy-Toxicity Trade-Offs .pdf 151.0 KB
Ba-Ca to Ce-Cu/Bayesian Two-Stage Design for Phase II Clinical Trials.pdf 150.7 KB
Ka-Mu/Multicollinearity.pdf 149.5 KB
Ka-Mu/Logistic Regression in Three-Point Designs.pdf 145.9 KB
Ba-Ca to Ce-Cu/Bioassay.pdf 145.6 KB
Ka-Mu/Coefficients in Medical Research.pdf 141.8 KB
No-Pr/Ordered Multiple Class Receiver Operating Characteristic (ROC) Analysis.pdf 139.2 KB
Da-Fa to Fo-In/Enrichment Design.pdf 138.1 KB
Qt-St to Su-Zs/Structural Equation Model.pdf 137.7 KB
Ac-As/Analysis of 2 K Tables .pdf 136.8 KB
Ba-Ca to Ce-Cu/Bioinformatics.pdf 133.6 KB
Da-Fa to Fo-In/Ethnic Factors.pdf 132.0 KB
Ba-Ca to Ce-Cu/Clinical Pharmacology.pdf 131.6 KB
Ka-Mu/Missing Values in Repeated Measurement Designs.pdf 127.7 KB
No-Pr/Principal Component Analysis.pdf 125.3 KB
Ba-Ca to Ce-Cu/Clinical Trial Simulations for Later Development Phases.pdf 123.5 KB
Ba-Ca to Ce-Cu/Clinical Trials.pdf 123.5 KB
Ac-As/Adaptive Designs.pdf 123.4 KB
No-Pr/Onset of Action.pdf 119.9 KB
Qt-St to Su-Zs/Statistical Tests for Biomarker Development with Applications to Genetics Data.pdf 119.0 KB
Ba-Ca to Ce-Cu/Center Weighting in Multicenter Trials.pdf 118.2 KB
Ba-Ca to Ce-Cu/Correlated Probit Model.pdf 115.8 KB
Qt-St to Su-Zs/Testing for Qualitative Interaction.pdf 111.0 KB
Ac-As/Alpha Spending Function.pdf 106.7 KB
Da-Fa to Fo-In/Group Sequential Tests and Variance Heterogeneity in Clinical Trials.pdf 106.6 KB
No-Pr/Power.pdf 103.8 KB
Ac-As/Analysis of Clustered Binary Data.pdf 102.4 KB
Ba-Ca to Ce-Cu/Clinical Trial Simulation.pdf 101.3 KB
Ac-As/Analysis of Repeated Measures Data with Missing Values- An Overview of Methods .pdf 99.8 KB
Ba-Ca to Ce-Cu/Bayesian Methods in Meta-Analysis.pdf 98.4 KB
Qt-St to Su-Zs/Trend Estimation.pdf 97.5 KB
Qt-St to Su-Zs/Specifications.pdf 97.0 KB
Da-Fa to Fo-In/Generalized Estimating Equations (GEE) Method- Sample Size Estimation.pdf 92.1 KB
Qt-St to Su-Zs/Risk Ratio Analysis.pdf 91.6 KB
Qt-St to Su-Zs/USP Tests.pdf 90.6 KB
Ba-Ca to Ce-Cu/Clinical Trial Simulations for Earlier Development Phases.pdf 88.6 KB
No-Pr/Proportion of Treatment Effect.pdf 87.1 KB
Qt-St to Su-Zs/Sequential Estimation for the Additive Hazards Rate Model with Staggered Entry.pdf 87.0 KB
Da-Fa to Fo-In/Factor Analysis.pdf 86.1 KB
Ka-Mu/McNemar's Test.pdf 85.1 KB
Qt-St to Su-Zs/Stuart-Maxwell Test.pdf 80.5 KB
Ka-Mu/Local Influence Analysis.pdf 76.3 KB
Ac-As/ANCOVA Approach for Premarketing Shelf Life Determination with Multiple Factors .pdf 72.4 KB
Qt-St to Su-Zs/Z-Score.pdf 69.0 KB
Ba-Ca to Ce-Cu/Bracketing Design.pdf 60.5 KB
Qt-St to Su-Zs/Screening Design.pdf 59.9 KB

Encyclopedia of Biopharmaceutical Statistics 2nd Ed. - (Malestrom)

File List

Download Torrent

Related Resources

Copyright Infringement